Correlation Between Nurix Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nurix Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Nurix Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Nurix Therapeutics and Edgewise Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Nurix and Edgewise is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Nurix Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Nurix Therapeutics is expected to generate 1.37 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, Nurix Therapeutics is 1.18 times less risky than Edgewise Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 2,703 in Edgewise Therapeutics on November 2, 2024 and sell it today you would earn a total of 97.00 from holding Edgewise Therapeutics or generate 3.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nurix Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Nurix Therapeutics |
| Edgewise Therapeutics |
Nurix Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nurix Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Nurix Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Nurix Therapeutics vs. Foghorn Therapeutics | Nurix Therapeutics vs. Shattuck Labs | Nurix Therapeutics vs. Monte Rosa Therapeutics | Nurix Therapeutics vs. Kymera Therapeutics |
| Edgewise Therapeutics vs. Surrozen | Edgewise Therapeutics vs. Armata Pharmaceuticals | Edgewise Therapeutics vs. Pasithea Therapeutics Corp | Edgewise Therapeutics vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets |